PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy
{{output}}
Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide. Low-density lipoprotein cholesterol (LDL-C) is the primary cause of ASCVD and reducing LDL-C levels with statin therapy significantly reduces ASCVD risk; however, sign... ...
